Taskinen MR - Search Results

1

Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel.

Borén J, Chapman MJ, Krauss RM, Packard CJ, Bentzon JF, Binder CJ, Daemen MJ, Demer LL, Hegele RA, Nicholls SJ, Nordestgaard BG, Watts GF, Bruckert E, Fazio S, Ference BA, Graham I, Horton JD, Landmesser U, Laufs U, Masana L, Pasterkamp G, Raal FJ, Ray KK, Schunkert H, Taskinen MR, van de Sluis B, Wiklund O, Tokgozoglu L, Catapano AL, Ginsberg HN. Borén J, et al. Among authors: taskinen mr. Eur Heart J. 2020 Jun 21;41(24):2313-2330. doi: 10.1093/eurheartj/ehz962. Eur Heart J. 2020. PMID: 32052833 Free PMC article. No abstract available.

2

Metabolism of HDL apolipoprotein A-I and A-II in type 1 (insulin-dependent) diabetes mellitus.

Taskinen MR, Kahri J, Koivisto V, Shepherd J, Packard CJ. Taskinen MR, et al. Diabetologia. 1992 Apr;35(4):347-56. doi: 10.1007/BF00401202. Diabetologia. 1992. PMID: 1516763

3

Effect of insulin therapy on metabolic fate of apolipoprotein B-containing lipoproteins in NIDDM.

Taskinen MR, Packard CJ, Shepherd J. Taskinen MR, et al. Diabetes. 1990 Sep;39(9):1017-27. doi: 10.2337/diab.39.9.1017. Diabetes. 1990. PMID: 2200727

4

Thyroid replacement therapy and its influence on postheparin plasma lipases and apolipoprotein-B metabolism in hypothyroidism.

Packard CJ, Shepherd J, Lindsay GM, Gaw A, Taskinen MR. Packard CJ, et al. Among authors: taskinen mr. J Clin Endocrinol Metab. 1993 May;76(5):1209-16. doi: 10.1210/jcem.76.5.8496312. J Clin Endocrinol Metab. 1993. PMID: 8496312

5

In vivo metabolism of apo A-I and apo A-II in subjects with apo A-I(Lys107-->0) associated with reduced HDL cholesterol and Lp(AI w AII) deficiency.

Tilly-Kiesi M, Packard CJ, Kahri J, Ehnholm C, Shepherd J, Taskinen MR. Tilly-Kiesi M, et al. Among authors: taskinen mr. Atherosclerosis. 1997 Feb 10;128(2):213-22. doi: 10.1016/s0021-9150(96)05992-8. Atherosclerosis. 1997. PMID: 9050778

6

Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM.

Malmström R, Packard CJ, Caslake M, Bedford D, Stewart P, Yki-Järvinen H, Shepherd J, Taskinen MR. Malmström R, et al. Among authors: taskinen mr. Diabetologia. 1997 Apr;40(4):454-62. doi: 10.1007/s001250050700. Diabetologia. 1997. PMID: 9112023

7

Metabolic basis of hypotriglyceridemic effects of insulin in normal men.

Malmström R, Packard CJ, Watson TD, Rannikko S, Caslake M, Bedford D, Stewart P, Yki-Järvinen H, Shepherd J, Taskinen MR. Malmström R, et al. Among authors: taskinen mr. Arterioscler Thromb Vasc Biol. 1997 Jul;17(7):1454-64. doi: 10.1161/01.atv.17.7.1454. Arterioscler Thromb Vasc Biol. 1997. PMID: 9261280

8

Effects of insulin and acipimox on VLDL1 and VLDL2 apolipoprotein B production in normal subjects.

Malmström R, Packard CJ, Caslake M, Bedford D, Stewart P, Yki-Järvinen H, Shepherd J, Taskinen MR. Malmström R, et al. Among authors: taskinen mr. Diabetes. 1998 May;47(5):779-87. doi: 10.2337/diabetes.47.5.779. Diabetes. 1998. PMID: 9588450 Clinical Trial.

9

Effect of heparin-stimulated plasma lipolytic activity on VLDL APO B subclass metabolism in normal subjects.

Malmström R, Packard CJ, Caslake M, Bedford D, Stewart P, Shepherd J, Taskinen MR. Malmström R, et al. Among authors: taskinen mr. Atherosclerosis. 1999 Oct;146(2):381-90. doi: 10.1016/s0021-9150(99)00153-7. Atherosclerosis. 1999. PMID: 10532694 Clinical Trial.

10

Diabetic dyslipidaemia.

Adiels M, Olofsson SO, Taskinen MR, Borén J. Adiels M, et al. Among authors: taskinen mr. Curr Opin Lipidol. 2006 Jun;17(3):238-46. doi: 10.1097/01.mol.0000226115.97436.c0. Curr Opin Lipidol. 2006. PMID: 16680028 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

596 results

Search Page